← Back to Search

Amino Acid Supplement

Barley Lysine Availability for Healthy Subjects

N/A
Waitlist Available
Led By Glenda Courtney-Martin, PhD
Research Sponsored by The Hospital for Sick Children
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Healthy with no known clinical condition which would affect protein or AA metabolism, ex. Diabetes
Not on any medications that could affect protein or amino acid metabolism e.g. steroids
Must not have
Unwillingness to participate or unable to tolerate the diet
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 hrs
Awards & highlights
No Placebo-Only Group

Summary

This trial assessed the effect of different cooking methods on the lysine availability of barley.

Who is the study for?
This trial is for healthy young men aged 18-40 with stable body weight, not on medication affecting protein metabolism like steroids. They must have no clinical conditions such as diabetes that affect protein or amino acid metabolism and no recent significant weight changes.
What is being tested?
The study examines how the body uses lysine from barley, focusing on the impact of cooking methods on its availability. Barley's low lysine content affects protein synthesis, which is crucial for growth and bodily functions.
What are the potential side effects?
Since this trial involves consuming barley prepared in different ways, side effects are minimal but may include potential allergic reactions to ingredients used in the study diets.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am healthy and do not have conditions like diabetes that affect protein metabolism.
Select...
I am not taking steroids or any drugs that affect protein in my body.
Select...
I am a man aged between 18 and 40.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am not willing or able to follow the study's diet plan.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 hrs
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 hrs for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Phenylalanine Oxidation

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Meabolic Availabiliy of BarleyExperimental Treatment1 Intervention
Healthy adult men

Find a Location

Who is running the clinical trial?

The Hospital for Sick ChildrenLead Sponsor
711 Previous Clinical Trials
6,958,273 Total Patients Enrolled
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,392 Previous Clinical Trials
26,529,435 Total Patients Enrolled
Glenda Courtney-Martin, PhDPrincipal InvestigatorAssociate Scientist
5 Previous Clinical Trials
159 Total Patients Enrolled

Media Library

Barley (Amino Acid Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT03907020 — N/A
Healthy Subjects Research Study Groups: Meabolic Availabiliy of Barley
Healthy Subjects Clinical Trial 2023: Barley Highlights & Side Effects. Trial Name: NCT03907020 — N/A
Barley (Amino Acid Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03907020 — N/A
~5 spots leftby May 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top